hypercoagulability – Page 13 – Communicable Diseases Research

D-Dimer-Driven Anticoagulation Reduces Mortality in Intubated COVID-19 Patients: A Cohort Study With a Propensity-Matched Analysis

Medicine

Published on 2021-02-042022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

Potential mechanisms of cerebrovascular diseases in COVID-19 patients

COVID-19 환자의 뇌혈관 질환의 잠재적 기전

Review

Published on 2021-02-012022-09-11
Journal: Journal of Neurovirology [Category] 치료기술, 치료제,

[키워드] ACE2 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 affected aggravate Alter angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 antibody antiphospholipid antibodies Atherosclerosis attack Blood Blood viscosity cause cerebrovascular Cerebrovascular disease cerebrovascular diseases Clinical practice Coagulation coronavirus disease Coronavirus disease 2019 Coronavirus-2 COVID-19 COVID-19 infection COVID-19 outbreak COVID-19 patient COVID-19 patients CVD Disruption dysfunction Effect endothelial cells endothelial damage enzyme fibrinolysis followed by greater hemorrhage hypercoagulability hyperglycemia immune Immune complexes immunothrombosis IMPROVE Inflammation inflammatory cascade investigated involved leads mechanism moment neurological neutrophil Neutrophil extracellular trap Neutrophil extracellular traps Occurrence offered outbreak outcome oxidative stress patients plasma Potential potential risk progression promote Psychological Psychological stress Renin renin-angiotensin system respiratory respiratory manifestations resulting risk SARS-CoV-2 Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe cases Stress stroke therapeutic thrombosis Treatment Trigger upregulation vascular endothelial cell vascular endothelial cells
[DOI] 10.1007/s13365-021-00948-2 PMC 바로가기 [Article Type] Review

Coagulation dysfunction in ICU patients with coronavirus disease 2019 in Wuhan, China: a retrospective observational study of 75 fatal cases

Observational Study

Published on 2021-01-312022-10-04
Journal: Aging (Albany NY) [Category] MERS, SARS, 임상,

Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients

Observational Study

Published on 2021-01-252022-10-04
Journal: Annals of Medicine [Category] SARS, 임상,

[키워드] Admission anticoagulant therapy anticoagulation anticoagulation treatment case sery change Comorbidity COVID-19 Critically ill patient Evidence heparin Hospitalization hypercoagulability hypercoagulable Hypoesthesia hypovolaemia ICUs Ilio-psoas haematoma incidence increased risk indication Infection Inpatient Inpatients intensive care unit Italy lack lower limbs material molecular observation period optimal dose over Pain Pneumonia reduce regimen reported Result Rome SARS-COV-2 infection SARS-CoV-2 pneumonia serious complication Seven severe COVID-19 Spontaneous subject Symptom the cytokine storm the SARS-CoV-2 therapy thrombosis thrombotic risk Treatment triggered with COVID-19
[DOI] 10.1080/07853890.2021.1875498 PMC 바로가기 [Article Type] Observational Study

COVID-19 Induced Bilateral Lower Limb Ischemia and Visceral Infarcts

Cardiac/Thoracic/Vascular Surgery

Published on 2021-01-192022-10-31
Journal: Cureus [Category] COVID-19,

Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities

COVID-19 및 기타 호흡기 바이러스 감염에서 과응고 가능성의 임상 및 실험실 특징은 동반 질환이 거의 없는 주로 젊은 성인에서

Article

Published on 2021-01-192022-09-10
Journal: Scientific Reports [Category] MERS, 치료기술,

[키워드] activated activated partial thromboplastin time Analysis approach Biomarkers caused changes in clinical Coagulation Coagulation parameters Comorbidity Course COVID-19 Epidemiology event Factors haemostasis highest hospitalized COVID-19 patient hypercoagulability Infection Infectious diseases Laboratory laboratory feature Mild Mild disease Myocardial infarction not differ occurred parameter partial thromboplastin time Patient patients pharmacological profiles Prothrombin time prothrombotic reported Research respiratory respiratory viral respiratory viral infection retrospective cohort study risk SARS-CoV-2 Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 severe COVID-19 significantly higher single-center Thromboprophylaxis thrombotic Thrombotic complications Thrombotic events two group venous Viral viral infection with mild disease
[DOI] 10.1038/s41598-021-81166-y PMC 바로가기 [Article Type] Article

COVID-19 With Preexisting Hypercoagulability Digestive Disease

Medicine

Published on 2021-01-132022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

A rapid screening classifier for diagnosing COVID-19

코로나19 진단을 위한 신속한 선별 분류기

Research Paper

Published on 2021-01-092022-09-12
Journal: International Journal of Biological Sciences [Category] MERS, 진단,

[키워드] Accuracy an area applied approach artificial intelligence AUC caused chest X-ray Classifier classifiers clinical feature Clinical features Clinical finding Clinical findings Computed tomography coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic CXR deep learning demonstrated diagnosing Diagnosis diagnostic Diagnostic accuracy diarrhea Efficacy extension feature Fever functional fused global pandemic hypercoagulability Influenza less non-severe cases patients with COVID-19 performed Physicians Pneumonia Radiation rationale Safe sensitivity Severe case severe cases specificity with COVID-19
[DOI] 10.7150/ijbs.53982 PMC 바로가기 [Article Type] Research Paper

Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients

Physiology

Published on 2021-01-082022-10-31
Journal: Frontiers in Physiology [Category] COVID-19,

[키워드] d-dimer anticoagulation blood flow Complete Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients Critically ill critically ill patients deep Deep vein thrombosis distal DVT elevated endothelial fibrinogen hemostasis disorder Hospitalized hypercoagulability ICU Ill increase increase in Inflammatory Influenza Injury intensive care lesion lower limb mechanical ventilation mechanically ventilated muscular optimal dose paralysis Patient phenotype Positive end-expiratory pressure Prevalence Prophylactic Protein prothrombotic proximal question raising reactive reflected risk severe pneumonia shown Thromboprophylaxis thrombosis Vein venous Venous return venous stasis von Willebrand factor
[DOI] 10.3389/fphys.2020.608788 PMC 바로가기 [Article Type] Physiology

Fatal pulmonary arterial thrombosis in a COVID-19 patient, with asymptomatic history, occurred after swab negativization

Case Report

Published on 2021-01-062022-10-29
Journal: Thrombosis Journal [Category] COVID-19,

[키워드] Analysis Antithrombotic Asymptomatic Asymptomatic COVID-19 Asymptomatic individuals asymptomatic patient bilateral pneumonia Cardiomyopathy Complete contribute COVID-19 COVID-19 patient death develop diagnostic distress drug early treatment Evidence form heart heterogeneous histopathological hypercoagulability Inflammatory kidneys lesion liver lung lung tissue main pulmonary artery Mild moderate Modification occurred pathological change pathophysiological mechanism Patient Post-mortem provide recommendation reported risk SARS-CoV-2 SARS-CoV-2 infected individual SARS-COV-2 infection spleen Swab Symptoms thrombosis thrombotic thrombotic complication Thrombotic complications Thrombus Topic Treatment Vascular was performed whole body
[DOI] 10.1186/s12959-020-00255-6 PMC 바로가기 [Article Type] Case Report